Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 21.18 is 389% above its 3-year average of 4.33, near the high end of its 3-year range (0.00–28.88).
As of the fiscal period ended Tuesday, June 30, 2026. 52.55% above its 12-month average of 13.88.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 21.18.
CURRENT RATIO
21.18
CURRENT RATIO AVG TTM
13.88
CURRENT RATIO AVG 3Y
4.72
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+52.55%
CURRENT VS 3Y AVG
+348.57%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
+489.95%
vs the sector median at left
Palvella Therapeutics, Inc.
Market Cap
$1.87B
Current Ratio
21.18
TTM Avg
13.88
3Y Avg
4.72
5Y Avg
N/A
Market Cap
$1.89B
Current Ratio
10.22
TTM Avg
11.68
3Y Avg
12.23
5Y Avg
12.24
Market Cap
$1.91B
Current Ratio
3.84
TTM Avg
3.30
3Y Avg
3.38
5Y Avg
3.69
Market Cap
$1.82B
Current Ratio
16.31
TTM Avg
13.02
3Y Avg
9.73
5Y Avg
8.18
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palvella Therapeutics, Inc. (PVLA) | $1.87B | 21.18 | 13.88 | 4.72 | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 9.69 | 5.24 | 4.11 | 4.46 |
| Azenta, Inc. (AZTA)vs › | $1.85B | 2.50 | 3.53 | 6.11 | 4.96 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | 10.22 | 11.68 | 12.23 | 12.24 |
| Astrana Health, Inc. (ASTH)vs › | $1.84B | 1.23 | 1.57 | 2.04 | 2.44 |
| Novavax, Inc. (NVAX)vs › | $1.84B | 2.33 | 1.55 | 1.13 | 1.26 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.91B | 3.84 | 3.30 | 3.38 | 3.69 |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 16.31 | 13.02 | 9.73 | 8.18 |
| Novocure Ltd (NVCR)vs › | $1.82B | 2.89 | 2.18 | 4.29 | 5.58 |
| Immunome, Inc. (IMNM)vs › | $1.93B | 15.08 | 9.38 | 7.12 | 8.07 |
Current Ratio
21.18
Quick Ratio
21.18
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 21.18 |
| 2026-03-31 | 28.88 |
| 2025-12-31 | 5.20 |
| 2025-09-30 | 6.49 |
| 2025-06-30 | 7.67 |
| 2025-03-31 | 8.84 |
| 2024-12-31 | 7.33 |
| 2024-09-30 | 4.82 |
| 2024-06-30 | 3.95 |
| 2024-03-31 | 2.34 |
| 2023-12-31 | 3.24 |
| 2023-09-30 | 2.05 |
| 2023-06-30 | 0.00 |
| 2023-03-31 | 0.00 |
